InspireMD (NSPR)
NASDAQ:NSPR
Holding NSPR?
Track your performance easily

InspireMD (NSPR) Income Statement

683 Followers

InspireMD Income Statement

Last quarter (Q2 2024), InspireMD's total revenue was $1.74M, an increase of 5.46% from the same quarter last year. In Q2, InspireMD's net income was $-7.91M. See InspireMD’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 6.57M$ 6.21M$ 5.17M$ 4.50M$ 2.48M$ 3.72M
Cost of Revenue
$ 4.40M$ 4.40M$ 4.05M$ 3.74M$ 2.40M$ 2.96M
Gross Profit
$ 1.92M$ 1.81M$ 1.12M$ 754.00K$ 83.00K$ 756.00K
Operating Expense
$ 28.69M$ 22.95M$ 19.83M$ 15.47M$ 10.46M$ 10.57M
Operating Income
$ -27.12M$ -21.14M$ -18.71M$ -14.72M$ -10.38M$ -9.82M
Net Non Operating Interest Income Expense
$ -1.29M$ -1.29M$ -250.00K---
Other Income Expense
$ -1.66M$ -1.29M$ -250.00K$ 157.00K$ 160.00K$ 200.00K
Pretax Income
$ -24.86M$ -19.85M$ -18.46M$ -14.87M$ -10.54M$ -10.02M
Tax Provision
$ 65.00K$ 65.00K$ 28.00K$ 45.00K$ 4.00K$ 24.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -25.52M$ -19.92M$ -18.49M$ -11.18M$ -8.14M$ -10.04M
Basic EPS
$ -0.48$ -0.82$ -2.35$ -2.03$ -0.46$ -4.80
Diluted EPS
$ -0.48$ -0.82$ -2.35$ -2.03$ -0.46$ -4.80
Basic Average Shares
$ 138.03M$ 24.27M$ 7.87M$ 7.35M$ 22.69M$ 2.09M
Diluted Average Shares
$ 138.03M$ 24.27M$ 7.87M$ 7.35M$ 22.69M$ 2.09M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 17.18M$ 27.35M$ 23.88M$ 19.21M$ 12.87M$ 13.54M
Interest Expense
------
Net Income From Continuing And Discontinued Operation
$ -25.52M$ -19.92M$ -18.49M$ -14.92M$ -10.54M$ -10.04M
Normalized Income
$ -6.44M--$ -11.75M--
EBIT
$ -20.58M$ -21.14M$ -18.71M$ -14.72M$ -10.38M$ -10.02M
EBITDA
$ -20.39M$ -20.91M$ -18.52M$ -14.55M$ -10.23M$ -10.17M
Currency in USD

InspireMD Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis